In the sophisticated landscape of synthetic glycobiology, the development of a robust microbial chassis is the cornerstone of successful biomanufacturing. However, genetic engineering often induces unforeseen metabolic burdens or regulatory imbalances that compromise strain stability and yield. At CD BioGlyco, our RNA sequencing (RNA-Seq)-based chassis validation service provides an indispensable high-resolution tool to bridge the gap between genotype and phenotype. By capturing the complete transcriptomic profile of an engineered organism, we enable researchers to validate the functional integrity of their chassis with unprecedented precision.
Our service utilizes next-generation sequencing (NGS) to quantify gene expression levels across the entire genome, identifying how synthetic pathways interact with endogenous host metabolism. This "system-wide" validation ensures that the chassis is not only genetically correct but also physiologically optimized for the production of complex glycans, glycoproteins, or other high-value metabolites. CD BioGlyco helps clients "debug" their synthetic constructs by pinpointing transcriptomic bottlenecks, allowing for rational iterative design that accelerates the path from laboratory proof-of-concept to industrial-scale production.
Key Technologies
NGS Technology
We utilize high-throughput sequencing and long-read sequencing technologies to achieve deep coverage of the transcriptome. This allows for the detection of low-abundance transcripts and the precise mapping of transcriptional boundaries, which is essential for understanding complex operon structures in non-model chassis.
Differential Gene Expression (DGE) Analysis
By comparing the engineered chassis against its wild-type or parental strain, we identify statistically significant changes in the expression of thousands of genes. This reveals the "metabolic cost" of heterologous expression and highlights compensatory mutations or stress responses.
Advanced Bioinformatics and Pathway Mapping
Our proprietary computational pipeline integrates transcriptomic data with metabolic models (e.g., KEGG or GO enrichment). This transforms raw sequencing reads into actionable insights, such as identifying limited precursor pools or identifying regulatory genes that require further tuning to enhance flux.
Empowering Precision Chassis Engineering Through RNA-Seq
CD BioGlyco provides a suite of services focused on the validation of chassis strains after genome editing or metabolic rewiring. Within the hierarchy of chassis development, this service falls under chassis strain validation, ensuring that the "Build" phase of the Design-Build-Test-Learn cycle meets the rigorous standards required for industrial application.
Our scope includes the validation of various microbial hosts, from common workhorses like Escherichia coli and Saccharomyces cerevisiae to specialized glycan-producing organisms and non-conventional yeast. We address the critical need to confirm that target gene knockouts, knock-ins, or point mutations have achieved the desired regulatory effect at the mRNA level. Beyond mere verification, we analyze the global impact of these edits on the host's fitness, checking for the upregulation of stress pathways or the downregulation of essential primary metabolism.
We implement these services through a customized approach: starting with standardized sample preparation to minimize transcriptional "noise," followed by library construction tailored to the organism's GC content and RNA structure. For clients developing minimal genomes, our RNA-Seq service is pivotal in confirming that the removal of "dispensable" genes hasn't inadvertently crippled vital metabolic functions. By providing a holistic view of the cellular state, CD BioGlyco ensures your chassis is a reliable, high-yielding platform ready for the complexities of synthetic glycobiology.
Workflow
Project Consultation and Experimental Design
Every project begins with a deep dive into the client's specific chassis and goals. We define the appropriate control groups, biological replicates, and environmental conditions (e.g., exponential vs. stationary phase) to ensure the data captured is biologically relevant and statistically robust.
High-Purity RNA Extraction and Quality Control (QC)
Using specialized lysis protocols for different cell wall types, we extract total RNA. Rigorous QC is performed using capillary electrophoresis to determine the RNA integrity number (RIN). Only samples meeting strict purity and integrity standards proceed to library preparation.
Library Preparation and Ribosomal RNA (rRNA) Depletion
To focus sequencing depth on the mRNA of interest, we perform efficient rRNA depletion. We then construct strand-specific libraries, which allow us to distinguish between sense and antisense transcription, a critical factor for identifying regulatory interference in synthetic gene circuits.
High-Throughput Sequencing
The prepared libraries are sequenced on our advanced NGS platforms. We ensure sufficient depth (e.g., 10-20 million reads per sample for microbes) to capture the full dynamic range of the transcriptome, ensuring even low-level transcription factors are accurately quantified.
Bioinformatic Processing and Data Mapping
Raw data undergoes trimming and filtering before being mapped to the reference genome. If a reference is unavailable, we offer de novo transcriptome assembly. We calculate normalized expression values (e.g., TPM or FPKM) and perform rigorous statistical tests for differential expression.
Functional Interpretation and Validation Report
The final stage involves mapping the data to metabolic pathways. We provide a comprehensive report detailing the status of synthetic constructs, identifying unintended metabolic shifts, and offering expert recommendations for the next iteration of chassis optimization.
Publication Data
DoI: 10.1186/1754-6834-6-113
Journal: Biotechnology for Biofuels
IF: 4.6
Published: 2013
Results: This study explores strategies to mitigate free fatty acid (FFA) toxicity and boost FFA production in engineered Synechococcus elongatus PCC 7942. FFA-producing strains (SE01, SE02) showed elevated reactive oxygen species (ROS) and increased cell membrane permeability, which impaired growth and photosynthesis. RNA-seq analysis identified 228 up-regulated and 223 down-regulated genes: stress response (e.g., heat shock proteins), nitrogen metabolism, and photosynthesis (PSII) genes were up-regulated, while carbon and hydrogen metabolism genes were down-regulated. Targeted mutagenesis of 15 genes (e.g., ROS-degrading proteins, porins, hypothetical proteins) improved growth, photosynthetic yield, and FFA yields. Porin knockouts (Δ1464, Δ1607) and overexpression of ROS-degrading proteins or specific hypothetical proteins reduced FFA toxicity. Comparative transcriptomics linked FFA stress to conserved cyanobacterial stress responses, identifying 6 core stress genes. These findings advance cyanobacterial biofuel development by uncovering genetic targets to alleviate FFA toxicity.
Fig.1 FFA production and physiological measurements for wild-type (7942) and FFA-producing strains (SE01 and SE02). (Ruffing, et al., 2013)
Applications
Metabolic Pathway Optimization
Validate the successful expression of heterologous enzymes and identify rate-limiting steps or metabolic bottlenecks in the synthesis of complex carbohydrates and specialized glycoconjugates.
Chassis Fitness Assessment
Evaluate the physiological impact of large-scale genome reduction or multi-gene deletions, ensuring the host retains robust growth characteristics and stress tolerance under industrial fermentation conditions.
Regulatory Circuit Debugging
Monitor the performance of synthetic genetic switches, oscillators, or feedback loops at the transcriptional level to ensure they function predictably within the specific cellular context of the host.
Non-Model Organism Domestication
Characterize the transcriptomes of novel or "wild" microbial strains to identify native promoters, terminators, and metabolic strengths, facilitating their conversion into efficient synthetic biology chassis.
Advantages
Glycobiology-Centric Expertise
Unlike general sequencing providers, CD BioGlyco understands the specific metabolic requirements for glycan production, allowing for more insightful data interpretation and pathway analysis.
High-Resolution Mapping
Our strand-specific RNA-Seq provides a detailed view of operon structure and antisense regulation, essential for troubleshooting complex synthetic constructs in microbial hosts.
Customized Bioinformatic Pipelines
We offer tailored data analysis that goes beyond simple gene lists, providing pathway enrichment and systems-level modeling specifically focused on the client's bioproduction goals.
Rigorous Quality Assurance
Every step, from RNA extraction to final data delivery, is governed by stringent QC protocols, ensuring that your validation results are accurate, reproducible, and publication-ready.
Frequently Asked Questions
Customer Review
"CD BioGlyco's RNA-Seq service was instrumental in debugging our engineered Pichia strain. They identified a significant downregulation in the ER-stress response pathway that we hadn't anticipated, which was limiting our protein secretion. Their analysis was clear and highly professional."
– T.N., Biopharmaceutical Research Institute
"The depth of the bioinformatic report provided by CD BioGlyco surpassed our expectations. They didn't just give us data; they gave us a roadmap for our next round of metabolic engineering. The turnaround was exactly as promised."
– Z.R., Synthetic Biology Startup
"Working with CD BioGlyco allowed us to move a non-model yeast into production much faster than we thought possible. Their ability to handle de novo assembly for our unique chassis was a game-changer for our glycan production project."
CD BioGlyco is dedicated to providing the most advanced validation tools for the synthetic biology community. Our RNA-Seq-based chassis validation ensures that your engineered organisms are not just living test tubes, but optimized, high-performance factories. By combining state-of-the-art sequencing with deep glycobiology expertise, we help you turn complex biological challenges into successful industrial solutions. Please feel free to contact us to help you design the perfect validation strategy.
Reference
Ruffing, A.M. RNA-Seq analysis and targeted mutagenesis for improved free fatty acid production in an engineered cyanobacterium. Biotechnology for Biofuels. 2013, 6(1): 113. (Open Access)
For research use only. Not intended for any clinical use.
Fig.1 FFA production and physiological measurements for wild-type (7942) and FFA-producing strains (SE01 and SE02). (Ruffing, et al., 2013)
